Expert Series: The Road Ahead: Navigating the FDA Update on Elamipretide for Barth syndrome Emily Grandahl Jun 2, 2025 Join MitoAction CEO, Kira Mann, Barth Syndrome Foundation CEO, Emily Milligan, and Stealth BioTherapeutics CEO, Reenie … [Read more...]